SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-046885
Filing Date
2023-04-18
Accepted
2023-04-18 19:43:29
Documents
2
Period of Report
2023-03-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2312963-8_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2312963-8_3seq1.xml 3 4764
2 EXHIBIT 24.1 tm2312963d8_ex24-1.htm EX-24.1 7468
  Complete submission text file 0001104659-23-046885.txt   13615
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Issuer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 350 FIFTH AVENUE, 72ND FLOOR, SUITE 7240 NEW YORK NY 10118
Business Address
Schlienger Katia (Reporting) CIK: 0001974233 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38869 | Film No.: 23828224